Breast cancer is a heterogeneous disease with at least four major sub-types, the clinical equivalents of genomic luminal A, luminal B, HER2 enriched and basal-like genotypes derived from genomic studies [8,9]. This evidence concerns the gene ERBB2 and breast carcinoma.